Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 503281 - 503300 out of 504621 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FD01) trastuzumab | TRAZIMERA 420MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerInc. |
| USA | (L01FD01) trastuzumab | TRAZIMERA 420MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerInc. |
| USA | (L01FF01) nivolumab | OPDIVO QVANTIG | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
| USA | (L01FF09) tislelizumab | TEVIMBRA 10MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Esophageal Squamous Cell Carcinoma;Carcinoma, Non-Small-Cell Lung;Small Cell Lung Carcinoma;Nasopharyngeal Carcinoma;Stomach Neoplasms | BeOneMedicinesUSA,Inc. |
| USA | (L01FF09) tislelizumab | TEVIMBRA 10MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Esophageal Squamous Cell Carcinoma;Carcinoma, Non-Small-Cell Lung;Small Cell Lung Carcinoma;Nasopharyngeal Carcinoma;Stomach Neoplasms | BeOneMedicinesUSA,Inc. |
| USA | (L01FG01) bevacizumab | ZIRABEV | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FG01) bevacizumab | ZIRABEV | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FG01) bevacizumab | ZIRABEV | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FG01) bevacizumab | ZIRABEV | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FX02) gemtuzumab ozogamicin | MYLOTARG 5MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerInc. |
| USA | (L01FX02) gemtuzumab ozogamicin | MYLOTARG 5MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerInc. |
| USA | (L01FX05) brentuximab vedotin | ADCETRIS 50MG/10.5ML INJ | 10.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | PfizerInc. |
| USA | (L01FX05) brentuximab vedotin | ADCETRIS 50MG/10.5ML INJ | 10.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | PfizerInc. |
| USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX13) enfortumab vedotin | PADCEV 20MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | PfizerInc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 20MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | PfizerInc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 30MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | PfizerInc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 30MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | PfizerInc. |
| USA | (L01FX17) sacituzumab govitecan | TRODELVY | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciences,Inc. |
Pages
